ArticlePloS one2015

1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug.

Martina Vermathen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.